استئصال سرطان البنكرياس في إسرائيل — احصل على ٣ خيارات مخصصة للعيادات

Israeli oncology centers perform advanced pancreatic cancer surgeries including Whipple procedures, distal and total pancreatectomies, and robotic-assisted resections. Specialized facilities like Sheba and Sourasky prioritize minimally invasive techniques and innovative downstaging protocols, such as NanoKnife and brachytherapy, to treat complex or previously inoperable tumors.

• Resection types: Whipple procedure, distal, total, and middle segment pancreatectomies are standard options.
• Minimally invasive: Surgeons use da Vinci robotic systems for high-precision, low-impact pancreatic resections.
• Advanced ablation: NanoKnife technology destroys cancer cells near vital vessels using non-thermal electrical pulses.
• Integrative protocols: HIPEC and AlphaTau DaRT radiotherapy are available for complex or metastatic cases.

Bookimed Expert Insight: Sourasky Medical Center treats 40,000 cancer patients annually, creating a high-volume environment where surgeons like Dr. Joseph Klauzner specialize specifically in the Whipple procedure. Data shows these tertiary centers often use Modified FOLFIRINOX chemotherapy to shrink tumors before surgery, successfully converting inoperable cases into candidates for resection.

Patient Consensus: Patients value the clinical trials available in Israel, noting that technologies like Oncosil brachytherapy provide hope for stage 3 cases. Many highlight the importance of reaching out to specialists at Sheba for complex vascular involvement.

Diagnostic steps in Israel prioritize precision imaging and molecular profiling within JCI-accredited centers like Sourasky or Sheba. Patients undergo endoscopic ultrasound with fine-needle aspiration for pathological confirmation. Advanced PET-CT and genetic testing, such as Foundation One CDx, guide surgical planning and neoadjuvant chemotherapy protocols.

• Endoscopic verification: Endoscopic ultrasound (EUS) with biopsy remains the gold standard for confirmation.
• Molecular profiling: Genetic testing like Tempus XT identifies germline and somatic mutations for planning.
• Advanced imaging: High-resolution PET-CT and MRI/MRCP map tumor involvement with nearby blood vessels.
• Functional screening: Specialists conduct EKG, stress tests, and spirometry to ensure cardiopulmonary fitness.

Bookimed Expert Insight: While many think a CT scan is enough, Israeli experts like Dr. Joseph Klauzner often require intraoperative staging. This matters because some small metastases only become visible during the procedure. Hospitals like Sourasky treat 40,000 cancer patients annually, meaning their teams recognize these subtle staging cues that less experienced clinics might miss.

Patient Consensus: Expect doctors to insist on neoadjuvant chemotherapy like FOLFIRINOX before the operating table. This approach aims to shrink tumors and significantly improve the success rates of complex Whipple procedures.

Surgeons in Israel maintain success rates aligned with global leaders, particularly at JCI-accredited centers like Sheba Medical Center and Sourasky Medical Center. Many senior specialists hold dual board certifications and international training from institutions like Memorial Sloan Kettering and Harvard, performing over 45,000 surgical procedures annually.

• Surgeon expertise: Leading specialists like Joseph Klauzner possess over 45 years of surgical experience.
• Clinical training: Roughly 60% of Israeli doctors complete advanced fellowships at top-tier international hospitals.
• Facility standards: Centers like Sheba rank among Newsweek Top 10 World Hospitals for quality.
• Advanced technology: Surgeons routinely utilize DaVinci robotic systems and Novalis TrueBeam STx for precision.

Bookimed Expert Insight: Israeli surgical centers are unique for their high patient volume, with Sourasky treating 40,000 cancer patients annually. This concentration of complex cases allows surgeons to maintain high proficiency specifically in difficult vascular resections. Some clinics even offer free airport transfers and interpreters, which simplifies logistics for international oncology patients.

Patient Consensus: Patients emphasize that success often involves converting unresectable tumors to surgical candidates through advanced chemotherapy. They advise confirming specific success rates for your cancer stage rather than general hospital statistics.

Neoadjuvant therapy is a standard treatment for pancreatic cancer in Israel, particularly for locally advanced cases. Specialized oncology centers provide FOLFIRINOX chemotherapy and targeted radiation to shrink tumors, increasing the success rate of Whipple surgery or minimally invasive robotic procedures performed by board-certified specialists.

• Standard protocol: FOLFIRINOX chemotherapy serves as the primary gold standard for preoperative treatment.
• Treatment duration: Patients typically undergo a 4–8 month chemotherapy regimen before surgical evaluation.
• Surgical timing: Surgeons schedule surgery within 6–8 weeks after radiation to prevent tissue fibrosis.
• Eligibility criteria: Doctors offer surgery mainly to patients showing positive responses to initial therapy.

Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center leverage advanced genetic testing, such as Foundation One CDx, to refine neoadjuvant protocols. This precision approach allows doctors to adjust chemotherapy earlier if a tumor isn't responding, which is critical for pancreatic cases where surgical windows are narrow.

Patient Consensus: Patients emphasize that surgery is not guaranteed and depends on how the tumor reacts to chemotherapy. Most appreciate that this early treatment helps identify if the cancer has spread before undergoing a major operation.

Israeli oncology centers perform complex pancreatic surgeries on advanced tumors using vascular resection and neoadjuvant conversion techniques. Specialized surgeons at Joint Commission International-accredited facilities integrate robotic-assisted approaches and cytoreductive surgery with Hyperthermic Intraperitoneal Chemotherapy to treat borderline resectable cases and select metastatic conditions.

• Advanced techniques: Surgeons utilize NanoKnife irreversible electroporation to treat tumors near critical blood vessels.
• Expert surgeons: Prof. Joseph Klauzner at Sourasky Medical Center provides over 45 years of experience.
• Surgical innovation: Robotic-assisted Whipple procedures at Sheba Medical Center enhance precision during complex abdominal resections.
• Multimodal care: Neoadjuvant chemotherapy and clinical trials like AlphaTau DaRT aim to shrink tumors.

Bookimed Expert Insight: Israeli centers like Sheba Medical Center are global leaders in bridging the gap between Stage 3 and surgery. While many regions decline advanced cases, surgeons here use specialized training from institutions like Memorial Sloan Kettering to perform major vascular resections. This aggressive approach aims to convert non-resectable patients into candidates for curative surgery.

Patient Consensus: Patients emphasize that surgery often depends on the tumor shrinking significantly after aggressive chemotherapy. Many recommend seeking specialized surgeons who are specifically experienced in complex vascular involvement for a final evaluation.

Israel is a global medical research hub offering numerous clinical trials for advanced oncology and rare conditions. Patients access groundbreaking therapies including CAR T-cell therapy, Alpha DaRT radiation, and personalized gene-targeted protocols. These trials must follow strict international Good Clinical Practice standards and Ministry of Health approval.

• Oncology research: Over 650 active oncology trials cover immunotherapy, gene therapy, and targeted drug combinations.
• Advanced radiation: Hadassah Medical Center hosts Alpha DaRT trials, showing 91–97% disease control in preliminary studies.
• Technological innovation: Clinical trials integrate NanoKnife irreversible electroporation and specialized thermal therapy using nanotechnology.
• Institutional leaders: Sheba Medical Center and Sourasky Medical Center manage high-volume, phase 1–3 multinational research studies.

Bookimed Expert Insight: Israeli research centers specialize in unique niche therapies like celiac plexus radiosurgery for pain. At Sheba Medical Center, the Advanced Biotherapy Center manufactures CAR-T cells in-house. This local production often makes enrollment faster than hospitals relying on external commercial labs.

Patient Consensus: Patients emphasize having professional pathology reports and scans ready before applying. While travel is required for treatment, preliminary eligibility is often confirmed through remote record reviews.

Hospital recovery after pancreatic cancer surgery in Israel typically lasts 5 to 23 days depending on the procedure and potential complications. Complex operations like the Whipple procedure usually require 5 to 7 days of inpatient monitoring, including 1 to 3 days in the intensive care unit.

• Whipple stay: Most patients spend 5 to 7 days in the hospital for uncomplicated recoveries.
• ICU monitoring: Expect 1 to 3 days in intensive care immediately following major pancreatic resections.
• Robotic surgery: Minimally invasive robotic distal pancreatectomy can reduce the stay to 3 to 5 days.
• Mobility goal: Surgeons encourage walking within 24 hours post-operation to prevent bowel issues and clots.

Bookimed Expert Insight: Israeli oncology centers like Sheba and Sourasky prioritize rapid recovery protocols. Data indicates that surgeons such as Professor Ido Nachmany use specialized techniques that allow a transition to liquid diets within 3 days. This early nutritional start often determines whether a patient stays 5 days or 2 weeks.

Patient Consensus: Patients emphasize the need for patience as the digestive system restarts. Many suggest preparing for a long-term healing process that continues for 3 to 10 months after leaving the hospital.